The estimated Net Worth of Fenel M Eloi is at least 53.9 千$ dollars as of 12 June 2024. Fenel Eloi owns over 7,777 units of 908 Devices stock worth over 53,921$ and over the last 4 years Fenel sold MASS stock worth over 0$.
Sign up
Fenel Eloi MASS stock SEC Form 4 insiders trading
Fenel has made over 6 trades of the 908 Devices stock since 2022, according to the Form 4 filled with the SEC. Most recently Fenel exercised 7,777 units of MASS stock worth 27,142$ on 12 June 2024.
The largest trade Fenel's ever made was exercising 7,777 units of 908 Devices stock on 12 June 2024 worth over 27,142$. On average, Fenel trades about 1,931 units every 105 days since 2021. As of 12 June 2024 Fenel still owns at least 15,450 units of 908 Devices stock.
You can see the complete history of Fenel Eloi stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Fenel Eloi's mailing address?
Fenel's mailing address filed with the SEC is C/O 908 DEVICES INC., 645 SUMMER STREET, BOSTON, MA, 02210.
Insiders trading at 908 Devices
Over the last 4 years, insiders at 908 Devices have traded over 16,182,689$ worth of 908 Devices stock and bought 826,585 units worth 15,798,345$ . The most active insiders traders include Keith Crandell、Kevin J. Knopp、E Kevin Hrusovsky. On average, 908 Devices executives and independent directors trade stock every 10 days with the average trade being worth of 64,663$. The most recent stock trade was executed by Christopher D. Brown on 7 August 2024, trading 6,328 units of MASS stock currently worth 9,998$.
What does 908 Devices do?
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
What does 908 Devices's logo look like?
Complete history of Fenel Eloi stock trades at 908 Devices
908 Devices executives and stock owners
908 Devices executives and other stock owners filed with the SEC include:
-
Dr. Kevin J. Knopp Ph.D.,
Co-Founder, CEO, Pres & Director -
Michael S. Turner Esq., J.D.,
VP, Sec. & Gen. Counsel -
Dr. Trent A. Basarsky Ph.D.,
VP of Corp. Devel. -
Maura Fitzpatrick,
VP of Product Management & Marketing -
Joseph H. Griffith IV,
CFO & Treasurer -
Dr. Scott Miller Ph.D.,
Co-founder & Director of MS Engineering -
Michael Jobin,
Co-Founder & Director of Product Devel. -
Andrew Bartfay,
Co-Founder & Director of Hardware Devel. -
Steve Araiza,
Co-founder & Software Architect -
Dr. Christopher David Brown Ph.D.,
Co-Founder, CTO, VP of R&D and Member of Scientific Advisory Board -
Michael S. Turner,
Chief Legal & Admin Officer -
John Kenneweg,
Vice President, Government -
Kevin J. Knopp,
President and CEO -
Sharon Kedar,
Director -
Venture Fund Vii, L.P.Arch ...,
-
John Michael Ramsey,
Director -
Jeffrey P. George,
-
Fenel M Eloi,
-
Christopher D. Brown,
Chief Product Officer -
Trent A. Basarsky,
VP, Corporate Development -
Joseph H. Iv Griffith,
Chief Financial Officer -
Nicolas Barthelemy,
-
Marcia Eisenberg,
-
Anthony Hunt,
-
Keith Crandell,
-
E Kevin Hrusovsky,
-
Mark Spoto,
-
Michele M. Leonhart,
-
Maura Fitzpatrick,
VP, Product Management & Mktg